--- title: "12 Health Care Stocks Moving In Thursday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/278883316.md" description: "In Thursday's pre-market session, several health care stocks experienced significant movements. SciSparc (SPRC) surged 35.1% to $5.2, while Codexis (CDXS) rose 27.55% to $1.62. Other gainers included Aethlon Medical (AEMD) up 16.92%, Agape ATP (ATPC) up 13.62%, and Incannex Healthcare (IXHL) up 11.89%. Conversely, Jin Medical International (ZJYL) fell 19.2% to $0.12, followed by SCWorx (WORX) down 15.62% and SILO Pharma (SILO) down 13.54%. Rapid Micro Biosystems (RPID) and P3 Health Partners (PIII) also saw declines of 9.11% and 8.71%, respectively." datetime: "2026-03-12T12:05:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/278883316.md) - [en](https://longbridge.com/en/news/278883316.md) - [zh-HK](https://longbridge.com/zh-HK/news/278883316.md) --- # 12 Health Care Stocks Moving In Thursday's Pre-Market Session ### Gainers - **SciSparc** (NASDAQ:SPRC) stock rose 35.1% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $19.5 million. - **Codexis** (NASDAQ:CDXS) stock increased by 27.55% to $1.62. The market value of their outstanding shares is at $114.7 million. As per the press release, Q4 earnings came out yesterday. - **Aethlon Medical** (NASDAQ:AEMD) shares increased by 16.92% to $1.93. The market value of their outstanding shares is at $2.1 million. - **Agape ATP** (NASDAQ:ATPC) shares moved upwards by 13.62% to $4.74. The market value of their outstanding shares is at $4.1 million. - **Incannex Healthcare** (NASDAQ:IXHL) shares increased by 11.89% to $6.68. The market value of their outstanding shares is at $71.3 million. - **Lunai Bioworks** (NASDAQ:LNAI) shares moved upwards by 11.3% to $0.21. The market value of their outstanding shares is at $4.5 million. ### Losers - **Jin Medical International** (NASDAQ:ZJYL) stock declined by 19.2% to $0.12 during Thursday's pre-market session. The company's market cap stands at $22.2 million. - **SCWorx** (NASDAQ:WORX) shares declined by 15.62% to $0.12. The market value of their outstanding shares is at $2.3 million. - **SILO Pharma** (NASDAQ:SILO) stock fell 13.54% to $0.32. The market value of their outstanding shares is at $4.8 million. - **Serina Therapeutics** (AMEX:SER) shares fell 10.0% to $1.35. The market value of their outstanding shares is at $16.1 million. - **Rapid Micro Biosystems** (NASDAQ:RPID) shares declined by 9.11% to $3.98. The market value of their outstanding shares is at $194.1 million. As per the press release, Q4 earnings came out today. - **P3 Health Partners** (NASDAQ:PIII) stock decreased by 8.71% to $2.83. The company's market cap stands at $10.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [PIII.US](https://longbridge.com/en/quote/PIII.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [SPRC.US](https://longbridge.com/en/quote/SPRC.US.md) - [SILO.US](https://longbridge.com/en/quote/SILO.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [ATPC.US](https://longbridge.com/en/quote/ATPC.US.md) - [WORX.US](https://longbridge.com/en/quote/WORX.US.md) - [CDXS.US](https://longbridge.com/en/quote/CDXS.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [IXHL.US](https://longbridge.com/en/quote/IXHL.US.md) - [AEMD.US](https://longbridge.com/en/quote/AEMD.US.md) ## Related News & Research - [Harvest Portfolios Group Inc. Grows Holdings in Abbott Laboratories $ABT](https://longbridge.com/en/news/287027124.md) - [P3 Health Partners Q1 revenue rises 4%, adjusted EBITDA turns positive](https://longbridge.com/en/news/286461585.md) - [Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients](https://longbridge.com/en/news/287144318.md) - [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md) - [BUZZ-Boston Scientific shares rise on $2 bln accelerated buyback](https://longbridge.com/en/news/286801797.md)